Form D · Pharmaceuticals
NextEvo, Inc.
Conshohocken, PA · CIK 0002053885
Offering snapshot reported Apr 29, 2026 · SEC filing
- Reported sold
- $725K Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 13, 2025 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$600,000 → $725,000
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 29, 2026 | Amendment | $725,000 | $125,000vs Feb 17, 2026 | 1 | SEC filing |
| Feb 17, 2026 | Amendment | $600,000 | $100,000vs Dec 17, 2025 | 1 | SEC filing |
| Dec 17, 2025 | Amendment | $500,000 | $200,000vs Mar 17, 2025 | 1 | SEC filing |
| Mar 17, 2025 | Amendment | $300,000 | $200,000vs Jan 29, 2025 | 1 | SEC filing |
| Jan 29, 2025 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-536585
Source: Form D, filed Apr 29, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ross Desmarais | Director, Executive |
| Howard Goodwin | Director, Executive |
| Edward H. Goodwin, Iii | Director |
| William Mc Comb | Director |
| John Mc Donagh | Executive |
| Gerry Mc Nally | Executive |
| Cornelius Merlini | Director |
| Gerald Stahlecker | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:Conshohocken, PA, 19428
Phone: 925-200-6766